text: A not-for-profit company, the MDC works with a range of UK innovators to advance projects and products towards clinical impact. In 2019, the company stated that it worked in four sectors:
  * Predictive biological models of human disease, for new drug testing
  * Predictive computational techniques for drug discovery
  * Collaboration between health service providers and government bodies
  * Collaboration on drug discovery between research charities and industry.
  In the same year, the number of staff increased from 40 to 75, and the company reported that its income comprised £8.5m from Innovate UK and £152,000 from collaborative research and development. After charging £7.1m to administrative expenses, the company reported a loss for the year of £16,000.
  In 2020, the company was given the task of setting up one of the first PCR analysis centres for COVID-19 tests – known as Lighthouse labs – elsewhere at the Alderley Park site. By 2021, this centre employed over 700 staff and had a stated capacity of 80,000 test samples per day.